Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Cancer and Metastasis Reviews
Metadata
Title
The Control of β-catenin and TCF During Embryonic Development and Cancer
Authors
Lucas Waltzer
Mariann Bienz
Publication date
01-05-1999
Publisher
Kluwer Academic Publishers
Published in
Cancer and Metastasis Reviews / Issue 2/1999
Print ISSN: 0167-7659
Electronic ISSN: 1573-7233
DOI
https://doi.org/10.1023/A:1006321324190

Other articles of this Issue 2/1999

Cancer and Metastasis Reviews 2/1999 Go to the issue

OriginalPaper

TGFβ Signaling Pathways and Human Diseases

OriginalPaper

The Impact of Developmental Biology on Cancer Research: An Overview

OriginalPaper

Cell Memory and Cancer – The Story of the Trithorax and Polycomb Group Genes

OriginalPaper

What is Drosophila Telling Us About Cancer?

OriginalPaper

Instructions for Authors

OriginalPaper

Control of EGF Receptor Signalling: Lessons from Fruitflies
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits